Volunteer Donate Get Help
 

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

New Inhibitor Drug Shows Promise

Published: June 23, 2017

Source: University of Pennsylvania

A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers at the Perelman School of Medicine at the University ... More >>.


Encouraging Therapy in Hodgkin Lymphoma

Published: June 06, 2017

Source: Roswell Park Cancer Institute

New research presented at the American Society of Clinical Oncology 53rd Annual Meeting in Chicago, shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemothe ... More >>.


Insurance Status at Diagnosis and Overall Survival

Published: June 01, 2017

Author: Carlos Harrison

Source: Cancer Therapy Advisor

A recent study of chronic myeloid leukemia (CML) patient outcomes found a direct and disturbingly high correlation between insurance status at diagnosis and overall survival.

For patients under 65 ye ... More >>.


Metabolism Harnessed

Published: May 17, 2017

Source: University of Georgia

University of Georgia researchers, with colleagues from the University of Tokyo, have identified a new drug target for the two most common types of myeloid leukemia, including a way to turn back the most agg ... More >>.


Stem-cell Transplants Show Limited Benefit

Published: May 15, 2017

Source: University of Pennsylvania School of Medicine

Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission of live longer that patients who do not ... More >>.


Novel Epigenetic Changes in Leukemia

Published: May 10, 2017

Source: UT Health Science Center

UT Health San Antonio researchers discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone ... More >>.


The Fruits of Our Funding

Published: April 27, 2017

Author: Andrea Greif

Source: Leukemia & Lymphoma Scociety

In just the past three years, we've seen a plethora of new therapies approved to treat patients with chronic lymphocytic leukemia and multiple myeloma. And the rapid advancing field of cancer immunotherapy h ... More >>.


Therapies Improve Outcomes in AML

Published: April 10, 2017

Author: Megan Garlapow, PhD

Source: Cancer Therapy Advisor

Over 70% of all patients with acute myeloid leukemia (AML) are 60 years or older. Worse prognoses tend to characterize this elderly population, due to frailty and comorbidities. Precision medicines have impr ... More >>.


LLS Expands Innovative Therapy

Published: April 05, 2017

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS) continues to advance the promising field of immunotherapy research, harnessing the body's own immune system to fight cancer, with a $4 million funding commitment in ... More >>.


Patients Traveling With CML

Published: April 04, 2017

Author: Lisa A. Thompson, PharmD, BCOP

Source: Oncology Nurse Advisor

During the summer, many patients with chronic myeloid lymphoma (CML) who are taking oral chemotherapy drugs have questions about taking their drugs while traveling. There are many things for patients and the ... More >>.


©2015 Stephanie Robinson Foundation | Privacy Policy